Use of GLP-1 receptor agonists in Prader-Willi Syndrome: report of six cases.

Fintini, Danilo; Grugni, Graziano; Brufani, Claudia; Bocchini, Sarah; Cappa, Marco; Crinò, Antonino

Fintini, Danilo; Grugni, Graziano; Brufani, Claudia; Bocchini, Sarah; Cappa, Marco; Crinò, Antonino.

Affiliation

Fintini D; Corresponding author: Antonino Crinò, antonino.crino@opbg.net.

Diabetes Care ; 37(4): e76-7, 2014 Apr.

Article in En | MEDLINE | ID: mdl-24652737

Subject(s)

Hypoglycemic Agents/therapeutic use; Prader-Willi Syndrome/drug therapy; Receptors, Glucagon/agonists; Adult; Blood Glucose/metabolism; Body Mass Index; Female; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin/metabolism; Humans; Hypoglycemic Agents/pharmacology; Male; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prader-Willi Syndrome / Receptors, Glucagon / Hypoglycemic Agents Limits: Adult / Female / Humans / Male Language: En Journal: Diabetes Care Year: 2014 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google